InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by McKechnie Duncan. Officer active across 2 companies, notably Vertex Pharmaceuticals INC / MA. In total, 8 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €2.8m. Activity tracked since 22 January 2026. The latest transaction was disclosed on 2 July 2026 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
McKechnie Duncan is a declarant associated with VERTEX PHARMACEUTICALS INC / MA and Vertex Pharmaceuticals INC / MA, where the listed role is EVP, Chief Commercial Officer. He has 8 filings in total, and across the 8 sampled filings from 2026-01-26 to 2026-07-07, sell transactions amount to EUR 2,827,880, with the modal transaction nature listed as Cession.